Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032)
Status:
Terminated
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate an improvement in physical functional recovery,
following administration of Drug for 24 weeks, in patients who have recently experienced a
hip fracture. This study will also evaluate the safety and tolerability of Drug.
This is an early phase trial and some specific protocol information is proprietary and not
publicly available at this time. (Full information is available to trial participants).